IPAMORELIN — 5 mg

Ipamorelin — 5 mg

Ipamorelin is a synthetic pentapeptide widely studied in research settings for its selective interaction with growth hormone–related signaling pathways. Researchers examine it for how it influences growth hormone secretion dynamics, circadian pulse timing, and downstream physiological markers without broadly activating other endocrine pathways.

Key Research Observations on Ipamorelin

Selective growth hormone release
Research literature describes ipamorelin as a growth hormone secretagogue that selectively stimulates growth hormone release while showing minimal activity on other pituitary hormones.

Minimal impact on cortisol and prolactin
Studies note ipamorelin’s high pathway specificity, observing little to no elevation in cortisol or prolactin levels compared to earlier-generation growth hormone–releasing compounds.

Role in circadian hormone patterns
Scientific investigation explores how ipamorelin may align with natural growth hormone pulse timing, particularly during sleep-associated secretion windows.

Interest in recovery and metabolic signaling research
Academic and preclinical research examines ipamorelin for its downstream signaling effects related to tissue recovery processes, protein synthesis pathways, and metabolic regulation mechanisms.